Correlation between Anthrax Lethal Toxin Neutralizing Antibody Levels and Survival in Guinea Pigs and Nonhuman Primates Vaccinated with the AV7909 Anthrax Vaccine Candidate

The anthrax vaccine candidate AV7909 is being developed as a next generation vaccine for a post-exposure prophylaxis (PEP) indication against anthrax. AV7909 consists of the Anthrax Vaccine Adsorbed (AVA, BioThrax(®)) bulk drug substance adjuvanted with the immunostimulatory oligodeoxynucleotide (OD...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine
Hlavní autoři: Savransky, Vladimir, Shearer, Jeffry D., Gainey, Melicia R., Sanford, Daniel C., Sivko, Gloria S., Stark, Gregory V., Li, Na, Ionin, Boris, Lacy, Michael J., Skiadopoulos, Mario H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580334/
https://ncbi.nlm.nih.gov/pubmed/28774566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.07.076
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky